Preetam Bekal

Midwest Clinical Research CenterDayton, Ohio - 45417 (937-424-1050) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS2
- SINCE2010

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
March 2010 - December 2011
Attention Deficit Disorder with Hyperactivity
Hyperkinesis
Opdc-34712 + Stimulant Therapy
Placebo + Stimulant Therapy



